The Drug Check eTEN Project to validate an on-line pan-European service

The objective of the Drug Check project is to validate an on-line, pan-European service, which gathers, organises, stores, makes available and presents information and data covering pharmaceuticals and their interactions. The service provides a user-friendly, reliable, intelligent and fast mechanism to accept questions and advanced queries, process them and offer accurate answers justified with the relevant bibliography, in order to assist healthcare professionals in making the proper decisions on medication prescriptions and pharmaceutical treatments both in and out of the hospital without interrupting healthcare delivery.

The service will be offered as a web-based/mobile application to healthcare professionals and institutions (e.g. hospitals, research organisations) following the ASP (application service provider) model, and its functionality will facilitate users to gain optimum access to the service at any time, from any place using various devices (computer, mobile phones, etc), at low cost and with enhanced userfriendliness and usability, in order to become a fast, reliable, accurate and effective companion to their everyday practise. A consortium of academic experts, IT integrators and Consulting companies will offer the service via Internet and mobile platforms to healthcare professionals.

It is envisaged that the service, after its deployment, will be an invaluable companion to a wide range of healthcare professionals, by enhancing their skills and empowering their decision-making processes, thus reducing unwanted effects and improving cost-effectiveness of patients' treatment and therefore contributing to better healthcare services for all citizens.

The DrugCheck service can be a valuable tool to all healthcare professionals who want fast access to trusted and verified information (through latest bibliography and publications) about potential interactions between pharmaceuticals. The service is not limited to the information offered from the drug's documentation provided from the company but offers information on mechanisms and results of interactions between pharmaceuticals.

DrugCheck service offers the following functionality:

  • Drug Interactions: The service describes the various types of interactions between pharmaceuticals (and also nutritional elements).
  • Detailed description of the interaction mechanism and the mechanism in case of special patients groups, location of interaction, pharmacokinetic properties etc.
  • Reference to the necessity of the measurement of the levels of some of the medicines already administered or scheduled to be administered to the patient, in order to decide the right dose of the medicine to minimise the risk of potential interactions
  • Effect of interaction and management of effects
  • References to source of knowledge (bibliography) and links to documentation.

For further information, please visit:
http://www.drug-check.org

Most Popular Now

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Ancient viral DNA in human genome guards against i…

Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new res...

The origin-of-life molecule, a key to cancer resea…

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cance...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...